Biological
Covid infection
Covid infection is a biological therapy with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed250%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
completed
A Comparison of Early Outcome of Surgical Management of Proximal Humerus Fracture in Adults During COVID-19 Pandemic- A Prospective Cohort Study
NCT06506006
unknown
Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease
NCT05212766
unknown
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196
completed
Covid-19 Infection and Long-term Cardiovascular Symptoms
NCT05715879
Clinical Trials (4)
Showing 4 of 4 trials
NCT06506006
A Comparison of Early Outcome of Surgical Management of Proximal Humerus Fracture in Adults During COVID-19 Pandemic- A Prospective Cohort Study
NCT05212766
Role of the Oral Microbiome & Mucosal Immunity in COVID-19 Disease
NCT05812196
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05715879
Covid-19 Infection and Long-term Cardiovascular Symptoms
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4